|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
214 a.a.
|
 |
|
|
|
|
|
|
|
207 a.a.
|
 |
|
|
|
|
|
|
|
61 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Antibody
|
 |
|
Title:
|
 |
Structure of p. Magnus protein l bound to a human igm fab.
|
|
Structure:
|
 |
Kappa light chain of ig. Chain: a, c. Fragment: 1-214. Heavy chain of ig. Chain: b, d. Fragment: 501-724. Protein l. Chain: e. Fragment: 820-880
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Cell: b-lymphocyte. Finegoldia magna. Organism_taxid: 1260. Strain: 3316. Plasmid: pkk223-3
|
|
Biol. unit:
|
 |
Pentamer (from
)
|
|
Resolution:
|
 |
|
2.70Å
|
R-factor:
|
0.215
|
R-free:
|
0.278
|
|
|
Authors:
|
 |
M.Graille,E.A.Stura,N.G.Housden,S.P.Bottomley,M.J.Taussig,B.J.Sutton, M.G.Gore,J.B.Charbonnier
|
Key ref:
|
 |
M.Graille
et al.
(2001).
Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins.
Structure,
9,
679-687.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
27-Nov-00
|
Release date:
|
10-Aug-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P01834
(IGKC_HUMAN) -
Immunoglobulin kappa constant from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
107 a.a.
214 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
9:679-687
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins.
|
|
M.Graille,
E.A.Stura,
N.G.Housden,
J.A.Beckingham,
S.P.Bottomley,
D.Beale,
M.J.Taussig,
B.J.Sutton,
M.G.Gore,
J.B.Charbonnier.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Peptostreptococcus magnus protein L (PpL) is a multidomain,
bacterial surface protein whose presence correlates with virulence. It consists
of up to five homologous immunoglobulin binding domains that interact with the
variable (VL) regions of kappa light chains found on two thirds of mammalian
antibodies. RESULTS: We refined the crystal structure of the complex between a
human antibody Fab fragment (2A2) and a single PpL domain (61 residues) to 2.7
A. The asymmetric unit contains two Fab molecules sandwiching a single PpL
domain, which contacts similar VL framework regions of two light chains via
independent interfaces. The residues contacted on VL are remote from the
hypervariable loops. One PpL-Vkappa interface agrees with previous biochemical
data, while the second is novel. Site-directed mutagenesis and
analytical-centrifugation studies suggest that the two PpL binding sites have
markedly different affinities for VL. The PpL residues in both interactions are
well conserved among different Peptostreptococcus magnus strains. The Fab
contact positions identified in the complex explain the high specificity of PpL
for antibodies with kappa rather than lambda chains. CONCLUSIONS: The PpL-Fab
complex shows the first interaction of a bacterial virulence factor with a Fab
light chain outside the conventional combining site. Structural comparison with
two other bacterial proteins interacting with the Fab heavy chain shows that
PpL, structurally homologous to streptococcal SpG domains, shares with the
latter a similar binding mode. These two bacterial surface proteins interact
with their respective immunoglobulin regions through a similar beta zipper
interaction.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 1.
Figure 1. PpL domain C* Complexed with Human IgM Fab 2A2(a)
Ribbon representation of the 2 Fab:1 PpL domain complex present
in the asymmetric unit. The PpL domain C* (red) is sandwiched
between two Fabs (blue and green). Light colors represent the
light chains, and dark colors represent the heavy chains.
Magenta highlights the CDR loops, as defined by Chothia [17],
and positions the Fab-PpL interfaces relative to the combining
site. Pseudo 2-fold axis symmetry relates the two Fabs, but both
interfaces are not symmetrical.(b) Stereoview of the 2F[o] -
F[c] electron density map contoured at 1s at the first V[L]-PpL
interface. The letter L precedes amino acids from the Fab light
chain. Green dotted lines depict the three hydrogen bonds
between Fab and PpL main-chain atoms. The three other hydrogen
bonds are shown in magenta and involve at least one side-chain
atom.(c) Ribbon representation of the V[L] region of Fab that
interacts with the PpL domain. Ten residues common to the first
and second interfaces are in yellow. Positions in pink are only
involved in the first interface, and those in light green are
implicated only in the second interface. All figures were
generated with MOLMOL [42] or TURBO-FRODO [43] 
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(2001,
9,
679-687)
copyright 2001.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.V.Sidorin,
and
T.F.Solov'eva
(2011).
IgG-Binding Proteins of Bacteria.
|
| |
Biochemistry (Mosc),
76,
295-308.
|
 |
|
|
|
|
 |
D.A.MacKenzie,
L.E.Tailford,
A.M.Hemmings,
and
N.Juge
(2009).
Crystal structure of a mucus-binding protein repeat reveals an unexpected functional immunoglobulin binding activity.
|
| |
J Biol Chem,
284,
32444-32453.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Yang,
J.Cao,
L.Q.Li,
X.Zhou,
Q.L.Chen,
W.T.Liao,
Z.M.Wen,
S.H.Jiang,
R.Xu,
J.A.Jia,
X.Pan,
Z.T.Qi,
and
W.Pan
(2008).
Evolutional selection of a combinatorial phage library displaying randomly-rearranged various single domains of immunoglobulin (Ig)-binding proteins (IBPs) with four kinds of Ig molecules.
|
| |
BMC Microbiol,
8,
137.
|
 |
|
|
|
|
 |
N.R.Watts,
G.Cardone,
J.G.Vethanayagam,
N.Cheng,
C.Hultgren,
S.J.Stahl,
A.C.Steven,
M.Sällberg,
and
P.T.Wingfield
(2008).
Non-canonical binding of an antibody resembling a naïve B cell receptor immunoglobulin to hepatitis B virus capsids.
|
| |
J Mol Biol,
379,
1119-1129.
|
 |
|
|
|
|
 |
S.H.Jiang,
J.F.Wang,
R.Xu,
Y.J.Liu,
X.N.Wang,
J.Cao,
P.Zhao,
Y.J.Shen,
T.Yang,
H.Yang,
J.A.Jia,
Q.L.Chen,
and
W.Pan
(2008).
Alternate arrangement of PpL B3 domain and SpA D domain creates synergistic double-site binding to VH3 and Vkappa regions of fab.
|
| |
DNA Cell Biol,
27,
423-431.
|
 |
|
|
|
|
 |
M.Zouali
(2007).
Exploitation of host signaling pathways by B cell superantigens--potential strategies for developing targeted therapies in systemic autoimmunity.
|
| |
Ann N Y Acad Sci,
1095,
342-354.
|
 |
|
|
|
|
 |
G.J.Silverman,
and
C.S.Goodyear
(2006).
Confounding B-cell defences: lessons from a staphylococcal superantigen.
|
| |
Nat Rev Immunol,
6,
465-475.
|
 |
|
|
|
|
 |
A.C.Roque,
M.A.Taipa,
and
C.R.Lowe
(2005).
Synthesis and screening of a rationally designed combinatorial library of affinity ligands mimicking protein L from Peptostreptococcus magnus.
|
| |
J Mol Recognit,
18,
213-224.
|
 |
|
|
|
|
 |
D.J.Brockwell,
G.S.Beddard,
E.Paci,
D.K.West,
P.D.Olmsted,
D.A.Smith,
and
S.E.Radford
(2005).
Mechanically unfolding the small, topologically simple protein L.
|
| |
Biophys J,
89,
506-519.
|
 |
|
|
|
|
 |
E.Nilsson,
and
A.Larsson
(2005).
Chicken anti-protein L for the detection of small amounts of protein L in the presence of IgG.
|
| |
Hybridoma (Larchmt),
24,
112-114.
|
 |
|
|
|
|
 |
I.S.Duarte,
R.d.e. .L.Zollner,
and
S.M.Bueno
(2005).
Protein L-agarose for adsorption of autoantibodies: a potential tool for extracorporeal treatment.
|
| |
Artif Organs,
29,
313-323.
|
 |
|
|
|
|
 |
V.Granata,
N.G.Housden,
S.Harrison,
C.Jolivet-Reynaud,
M.G.Gore,
and
E.A.Stura
(2005).
Comparison of the crystallization and crystal packing of two Fab single-site mutant protein L complexes.
|
| |
Acta Crystallogr D Biol Crystallogr,
61,
750-754.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Smith,
R.D'Argy,
M.Nilsson,
U.Yrlid,
J.de Jersey,
L.Björck,
and
M.J.Wick
(2004).
Whole-body autoradiography reveals that the Peptostreptococcus magnus immunoglobulin-binding domains of protein L preferentially target B lymphocytes in the spleen and lymph nodes in vivo.
|
| |
Cell Microbiol,
6,
609-623.
|
 |
|
|
|
|
 |
F.Ghiotto,
F.Fais,
A.Valetto,
E.Albesiano,
S.Hashimoto,
M.Dono,
H.Ikematsu,
S.L.Allen,
J.Kolitz,
K.R.Rai,
M.Nardini,
A.Tramontano,
M.Ferrarini,
and
N.Chiorazzi
(2004).
Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.
|
| |
J Clin Invest,
113,
1008-1016.
|
 |
|
|
|
|
 |
J.C.Peter,
G.Wallukat,
J.Tugler,
D.Maurice,
J.C.Roegel,
J.P.Briand,
and
J.Hoebeke
(2004).
Modulation of the M2 muscarinic acetylcholine receptor activity with monoclonal anti-M2 receptor antibody fragments.
|
| |
J Biol Chem,
279,
55697-55706.
|
 |
|
|
|
|
 |
M.Viau,
N.S.Longo,
P.E.Lipsky,
L.Björck,
and
M.Zouali
(2004).
Specific in vivo deletion of B-cell subpopulations expressing human immunoglobulins by the B-cell superantigen protein L.
|
| |
Infect Immun,
72,
3515-3523.
|
 |
|
|
|
|
 |
N.G.Housden,
S.Harrison,
H.R.Housden,
K.A.Thomas,
J.A.Beckingham,
S.E.Roberts,
S.P.Bottomley,
M.Graille,
E.Stura,
and
M.G.Gore
(2004).
Observation and characterization of the interaction between a single immunoglobulin binding domain of protein L and two equivalents of human kappa light chains.
|
| |
J Biol Chem,
279,
9370-9378.
|
 |
|
|
|
|
 |
M.Graille,
S.Harrison,
M.P.Crump,
S.C.Findlow,
N.G.Housden,
B.H.Muller,
N.Battail-Poirot,
G.Sibaï,
B.J.Sutton,
M.J.Taussig,
C.Jolivet-Reynaud,
M.G.Gore,
and
E.A.Stura
(2002).
Evidence for plasticity and structural mimicry at the immunoglobulin light chain-protein L interface.
|
| |
J Biol Chem,
277,
47500-47506.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |
|